Catalogo Ricerca UNIKORE

Catalogo Ricerca UNIKORE: [26724] Home page macrotipologia

Sfoglia

1 Contributo su Rivista 17262
- 1.1 Articolo in rivista 16356
- 1.2 Recensione in rivista 361
- 1.3 Scheda bibliografica 13
- 1.4 Nota a sentenza 116
- 1.5 Abstract in rivista 409
- 1.6 Traduzione in rivista 7

2 Contributo in Volume 3697
- 2.1 Contributo in volume (Capitolo o Saggio) 3261
- 2.2 Prefazione/Postfazione 151
- 2.3 Breve introduzione 50
- 2.4 Voce (in dizionario o enciclopedia) 117
- 2.5 Traduzione in volume 34
- 2.6 Recensione in volume 62
- 2.7 Schede di catalogo 22

3 Libro 835
- 3.1 Monografia o trattato scientifico 760
- 3.2 Concordanza 8
- 3.3 Indice 1
- 3.4 Bibliografia 3
- 3.5 Edizione critica 19
- 3.6 Pubblicazione di fonti inedite 10
- 3.7 Commento scientifico 12
- 3.8 Traduzione di libro 22

4 Contributo in Atti di Convegno (Proceeding) 4143
- 4.1 Contributo in Atti di convegno 2845
- 4.2 Abstract in Atti di convegno 1051
- 4.3 Poster 247

5 Altro 477
- 5.01 Composizione 7
- 5.02 Disegno 89
- 5.03 Design 1
- 5.04 Performance 3
- 5.05 Esposizione 4
- 5.06 Mostra 23
- 5.07 Manufatto 49
- 5.08 Prototipo d'arte e relativi progetti 2
- 5.09 Cartografia 23
- 5.10 Banca dati 7
- 5.11 Software 7
- 5.12 Altro 262

6 Brevetti 22
- 6.1 Brevetto 22

7 Curatele 288
- 7.1 Curatela 288

Prodotti recenti

Interobserver Agreement in Immunohistochemical Evaluation of Folate Receptor Alpha (FRα) in Ovarian Cancer: A Multicentre Study

Folate receptor alpha (FRα) is a high-affinity folate transporter overexpressed in various epithelial malignancies, particularly high-grade serous ovarian carcinoma. Given its restricted expression in normal tissues and accessibility in tumors, FRα is an emerging therapeutic target. Immunohistochemistry (IHC) is the standard method for FRα assessment; however, interpretation is semi-quantitative and prone to interobserver variability. This study aimed to evaluate interobserver agreement among...

HER2 intratumoral heterogeneity predicts response to neoadjuvant therapy in HER2-positive breast cancer: impact and interplay with HER3 expression

Intratumoral heterogeneity (ITH) of HER2 expression and HER3 upregulation have been associated with resistance to HER2-targeted therapies. However, their predictive role in the neoadjuvant setting remains controversial. We retrospectively analyzed 59 patients with HER2-positive invasive breast carcinoma treated with neoadjuvant chemotherapy and anti-HER2 agents at the Agostino Gemelli University Hospital (2018–2020). HER2 ITH was assessed on pre-treatment biopsies and residual tumors (when ap...

Mesonephric-like metaplasia of the endometrium in a woman treated with letrozole: morphological, immunohistochemical and molecular analysis

Endometrial mesonephric-like adenocarcinoma (MLA) is thought to arise from endometrial epithelium through a Müllerian-to-mesonephric transdifferentiation. However, no benign or precancerous mesonephric-like endometrial lesions have been reported so far. Herein, we describe the first case of endometrial mesonephric-like metaplasia. A 61-year-old woman who was treated with letrozole for 5 years underwent removal of an endometrial polyp. Histological examination highlighted an area of small roun...

HER2 in gynecological malignancies: Bridging the gap between standardized pathological assessment and precision therapy

HER2 is a transmembrane tyrosine kinase receptor involved in cell proliferation, survival, and differentiation. While its role in breast and gastric cancers is well established, increasing attention is being paid to HER2 expression in gynecologic malignancies. In endometrial cancer, HER2 overexpression is most commonly associated with serous endometrial carcinoma (SEC), where it occurs in approximately 30 % of cases and correlates with poor prognosis, platinum resistance, and TP53 mutations. ...

Rethinking certainty: a retrospective study on diagnostic revisions in gynecologic pathology

Objective: Expert pathology review plays a crucial role in gynecologic oncology, where diagnostic complexity can substantially affect patient management and medico-legal accountability. This study aimed to assess the frequency, nature, and impact of diagnostic revisions arising from second opinion evaluations of gynecologic lesions. Methods: We retrospectively analyzed 319 consecutive cases of gynecologic lesions submitted for second opinion review by a senior gynecologic pathologist at a ter...

Scopri

Accesso al fulltext

no fulltext26722